Common variable immunodeficiency (CVID) has a genetic component, but it is not strictly hereditary in the way most people imagine. Only about 10% to 20% of CVID cases in Western countries trace back to a single inherited gene mutation. The rest appear to involve a more complex mix of multiple genes, epigenetic changes, and possibly environmental factors. So having a family member with CVID does increase your risk, but most cases don’t follow a simple parent-to-child inheritance pattern.
How Often CVID Runs in Families
About 20% of people with CVID have a first-degree relative (parent, sibling, or child) with a related immune problem, most commonly selective IgA deficiency, a milder condition where the body produces little or none of one specific type of antibody. That’s a notable family clustering, but it also means the majority of CVID patients have no close relatives with any diagnosed immune deficiency at all.
When researchers screen the parents, siblings, and children of CVID patients, roughly 19% of those relatives show some kind of immunological abnormality, even if they haven’t been formally diagnosed. The risk appears somewhat higher among siblings than parents, and in one large study, affected mothers were the most commonly identified group among relatives at about 20%.
Single-Gene vs. Complex Inheritance
The genetics of CVID fall into two broad categories, and they look very different from each other.
In 10% to 20% of cases (in Western populations), a single gene mutation is responsible. These follow more traditional inheritance patterns, usually autosomal dominant, meaning you only need one copy of the faulty gene to potentially develop the condition. The most commonly involved gene is TNFRSF13B, which provides instructions for making a protein called TACI. TACI helps B cells mature and produce antibodies. More than 25 mutations in this gene have been linked to CVID, with the most common one (C104R) disrupting TACI’s ability to communicate with other proteins and ultimately preventing normal antibody production. Other genes involved include NFKB1, NFKB2, ICOS, and CD19, all of which play roles in how immune cells develop and function.
In communities with high rates of marriage between relatives, single-gene causes account for a much larger share, up to 68% of cases. This is because autosomal recessive mutations (where you need two copies of the faulty gene) become far more likely when both parents share ancestry.
For the remaining 80% to 90% of cases without a clear single-gene cause, the picture is murkier. The leading hypothesis is that most CVID is a complex disease where multiple gene variants each contribute a small effect, potentially combined with environmental or epigenetic influences. Think of it less like inheriting a single broken switch and more like inheriting a collection of dimmer switches that, together, turn immune function down too far.
Carrying a Gene Mutation Doesn’t Guarantee CVID
Even in families where a known CVID-causing mutation is present, not everyone who inherits it will develop symptoms. This is called variable penetrance, and it’s one of the most confusing aspects of CVID genetics. Two siblings can carry the exact same mutation, and one develops recurrent infections and low antibody levels while the other remains healthy.
That said, the majority of people carrying these dominant mutations do become symptomatic at some point in their lives. The timing varies widely. CVID can appear in childhood or not until the 20s, 30s, or later, which is part of why it’s so often diagnosed with a long delay. The variability in when and whether symptoms appear likely depends on other genes, immune system stressors, and factors researchers haven’t fully mapped yet.
What This Means for Family Members
If you have CVID and are wondering about risk to your children, siblings, or parents, the honest answer is that the risk is elevated but far from certain. Medical guidelines recommend that families with an affected member be offered screening and genetic counseling. This doesn’t necessarily mean full genetic sequencing for everyone. In many cases, a simple blood test measuring immunoglobulin levels in close relatives is a reasonable first step.
Genetic testing itself is not required to diagnose CVID. It’s most useful in specific situations: when the disease appears early in life, when the presentation is unusual, or when there’s a strong family history. If a specific mutation is identified in one family member, testing relatives for that same mutation becomes straightforward and can clarify who might need monitoring.
For families where no single-gene cause is found, which is the majority, the genetics are too complex to offer precise risk numbers. The roughly 19% to 20% rate of immune abnormalities in first-degree relatives is the best available estimate of how often family members are affected in some way, though many of those abnormalities are milder than full CVID.
The Bottom Line on Heredity
CVID is genetic in the sense that your genes are the primary driver of risk. It is hereditary in a meaningful minority of cases, about 15% to 35%, where a single identifiable mutation can be passed from parent to child. For most people with CVID, though, the genetic architecture is complex and not reducible to a single inherited gene. Family members face a higher-than-average risk of immune problems but are more likely than not to be unaffected.